Details for New Drug Application (NDA): 077525
✉ Email this page to a colleague
The generic ingredient in GABAPENTIN is gabapentin. There are twenty-nine drug master file entries for this compound. Seventy-five suppliers are listed for this compound. Additional details are available on the gabapentin profile page.
Summary for 077525
Tradename: | GABAPENTIN |
Applicant: | Sun Pharm Inds Ltd |
Ingredient: | gabapentin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 077525
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 077525
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GABAPENTIN | gabapentin | TABLET;ORAL | 077525 | ANDA | Sun Pharmaceutical Industries, Inc. | 62756-202 | 62756-202-01 | 100 TABLET, FILM COATED in 1 BOTTLE (62756-202-01) |
GABAPENTIN | gabapentin | TABLET;ORAL | 077525 | ANDA | Sun Pharmaceutical Industries, Inc. | 62756-202 | 62756-202-03 | 500 TABLET, FILM COATED in 1 BOTTLE (62756-202-03) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 600MG | ||||
Approval Date: | Aug 24, 2006 | TE: | AB1 | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 800MG | ||||
Approval Date: | Aug 24, 2006 | TE: | AB1 | RLD: | No |
Complete Access Available with Subscription